APOBEC3B and CD274 as Combined Biomarkers for Predicting Response to Immunotherapy in Urothelial Carcinoma of the Bladder

Immunotherapy has become a promising form of treatment for cancers. There is a need to predict response to immunotherapy accurately. In the UCSC Xena, pan-cancer analysis revealed a positive relationship between APOBEC3B (A3B) and tumor mutational burden (R = 0.28, P < 0.001) and microsatellite i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chuanhao, Cheng, Zhichao, Wang, Zhe, Zhao, Genghao, Yuan, Yonghui, Wang, Ruoyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557251/
https://www.ncbi.nlm.nih.gov/pubmed/36245972
http://dx.doi.org/10.1155/2022/6042334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557251/
https://www.ncbi.nlm.nih.gov/pubmed/36245972
http://dx.doi.org/10.1155/2022/6042334

Ejemplares similares